1. Academic Validation
  2. Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency

Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency

  • Cell Host Microbe. 2017 Apr 12;21(4):507-517.e5. doi: 10.1016/j.chom.2017.03.007.
Roberto Alfonso-Dunn 1 Anne-Marie W Turner 1 Pierre M Jean Beltran 2 Jesse H Arbuckle 1 Hanna G Budayeva 2 Ileana M Cristea 2 Thomas M Kristie 3
Affiliations

Affiliations

  • 1 Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814, USA.
  • 2 Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
  • 3 Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20814, USA. Electronic address: [email protected].
Abstract

The cellular transcriptional coactivator HCF-1 is required for initiation of herpes simplex virus (HSV) lytic Infection and for reactivation from latency in sensory neurons. HCF-1 stabilizes the viral Immediate Early (IE) gene enhancer complex and mediates chromatin transitions to promote IE transcription initiation. In infected cells, HCF-1 was also found to be associated with a network of transcription elongation components including the super elongation complex (SEC). IE genes exhibit characteristics of genes controlled by transcriptional elongation, and the SEC-P-TEFb complex is specifically required to drive the levels of productive IE mRNAs. Significantly, compounds that enhance the levels of SEC-P-TEFb also potently stimulated HSV reactivation from latency both in a sensory ganglia model system and in vivo. Thus, transcriptional elongation of HSV IE genes is a key limiting parameter governing both the initiation of HSV Infection and reactivation of latent genomes.

Keywords

P-TEFb; herpes simplex virus; host cell factor-1; latency; super elongation complex; transcriptional elongation.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-16462
    99.37%, CDK9 Inhibitor
    CDK